Improving antibiotic markets for long-term sustainability.

Yale journal of health policy, law, and ethics

Volumn 11, Issue 1, 2011, Pages 101-167

  Kesselheim, Aaron S ^a   Outterson, Kevin ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENERIC DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOMEDICINE; DRUG DEVELOPMENT; DRUG LEGISLATION; DRUG MANUFACTURE; ECONOMICS; FINANCIAL MANAGEMENT; HUMAN; LEGAL ASPECT; PATENT; REIMBURSEMENT; UNITED STATES;

ANTI-BACTERIAL AGENTS; BIOLOGICAL SCIENCE DISCIPLINES; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MICROBIAL; DRUGS, GENERIC; HUMANS; INTELLECTUAL PROPERTY; LEGISLATION, DRUG; ORPHAN DRUG PRODUCTION; PATENTS AS TOPIC; REIMBURSEMENT, INCENTIVE; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 79953146067     PISSN: 15353532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)